Pharma major Sun Pharmaceuticals has reported a consolidated net profit of Rs 795.5 crore for the quarter ended June 30, 2012.
The firm's consoldated net sales wer at Rs 2,658 crore for the April-June quarter.
It's EBITDA stood at Rs 1,242.2 crore for the quarter under review.
The company has declared that it will pay an interim dividend of Rs 4.25 per share.
At the Bombay Stock Exchange (BSE), share of Sun Pharma were trading at Rs 673 apiece, down 0.58% from the previous day's close at 2:35 pm.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app